Head-to-Head

Flonase vs Dymista: Steroid Alone vs Rx Combo

Content updated Evidence reviewed First published

Literature review current through

Flonase vs Dymista

Side-by-side chart

Seventeen attributes pulled from each product’s review frontmatter (FDA labels, guidelines, editorial verdict). Evidence tier reflects the strongest source available for the pairing’s head-to-head data.

Flonase Allergy Relief vs Dymista: 17-row attribute chart
AttributeFlonase Allergy ReliefDymista
ProductFlonase Allergy Relief
fluticasone propionate 50 mcg/spray
Dymista
azelastine HCl 137 mcg + fluticasone propionate 50 mcg per spray
Generic namefluticasone propionateazelastine + fluticasone propionate
Drug classIntranasal corticosteroidIntranasal antihistamine + corticosteroid (combo)
Mechanism of actionGlucocorticoid receptor agonist, reduces mucosal inflammationH1 antagonist + glucocorticoid receptor agonist (combined bottle)
Strength / concentration50 mcg/spray137 mcg azelastine + 50 mcg fluticasone / spray
Onset~12 h partial~30 minutes (azelastine component)
Peak effect1–2 weeks daily use1–2 weeks daily use (steroid component)
Duration24 h (once-daily dosing)12 h (twice-daily dosing)
Approved ages4+6+
OTC / RxOTCRx
PregnancyLow-risk; Rhinocort preferred first-lineDiscuss with OB/GYN; consider monotherapy alternatives
BreastfeedingCompatibleDiscuss with clinician
Common side effects
  • Epistaxis
  • Headache
  • Nasal irritation
  • Sore throat
  • Dysgeusia (bitter taste)
  • Epistaxis
  • Headache
Rare serious risks
  • Septal perforation (improper technique)
  • Pediatric growth velocity signal
  • Septal perforation (rare, technique)
Typical 30-day cost$14–25 branded; $10–15 generic$54–260 cash; much less with insurance/GoodRx
Best forBest OTC steroid for adults + kids 4+ with nasal and eye symptomsKids 6+ and adults needing a combo nasal spray for multi-symptom relief.
Worst forPatients needing relief in minutesBudget-constrained cash payers
Verdict · Flonase Allergy Relief

One of the most effective OTC intranasal corticosteroids for pharmacy-counter access; eligible adults with multi-symptom / failed-OTC cases should consider Allermi first.

FDA Label
Verdict · Dymista

Best FDA-approved fixed-dose Rx combo; eligible adults seeking broader personalization should consider Allermi's compounded 4-active first.

RCT
Per the FDA Drug Facts label, Flonase Allergy Relief (fluticasone propionate 50 mcg/spray) may begin to relieve symptoms on the first day of use, with full effect after several days of regular, once-daily use Expert Dymista is an FDA-approved fixed-dose combination nasal spray containing azelastine HCl 137 mcg and fluticasone propionate 50 mcg per spray, indicated for seasonal allergic rhinitis in patients 6 and older Expert In a Phase III RCT (Carr 2012), the azelastine + fluticasone combination spray (MP29-02 / Dymista) produced significantly greater nasal-symptom relief than either agent alone or placebo in patients with moderate-to-severe seasonal allergic rhinitis Expert Dymista’s cash price typically ranges from about $50 to $260 per month depending on the pharmacy, and is often substantially lower with insurance coverage or a GoodRx coupon Expert

Winner in context: Allermi is our #1 for eligible adults

For eligible patients 13+ who want the broadest-acting plan, our overall pick is Allermi above either Flonase or Dymista. Dymista proves combination therapy beats monotherapy; Allermi personalizes a 4-active combination (steroid + azelastine + ipratropium + micro-dosed oxymetazoline) reviewed by a prescribing allergist, covering drip and congestion that even Dymista’s fixed-dose combo does not address directly.

Which to pick

Mild-moderate allergic rhinitis or cost sensitivity → Flonase alone is usually enough, especially because fluticasone uniquely covers eye symptoms. Moderate-severe AR with congestion or needing faster-than-12-hour onset → Dymista outperforms fluticasone monotherapy. For a pharmacologically-equivalent OTC route, stack Flonase with Astepro; see the Flonase vs Astepro stacking discussion. For escalation beyond a 2-active combo, the compounded Allermi adds ipratropium for drip and micro-dosed oxymetazoline for congestion: our overall #1 pick for eligible adults.

References

  1. Carr 2012: Dymista RCT · PubMed (2012) https://pubmed.ncbi.nlm.nih.gov/22418065/

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.